2B32.Y

ICD-11 MMS 2026-01

Other specified immunodeficiency-associated lymphoproliferative disorders

Exclusions from above levels

  • 2E03 – Malignant neoplasm metastasis in bone or bone marrow
  • http://id.who.int/icd/entity/501778925 – Malignant neoplasm metastasis in lymph nodes
  • http://id.who.int/icd/entity/97145147 – Malignant neoplasm metastasis in thymus gland

Sibling codes

  • 2B32.0 – Post-transplant lymphoproliferative disorder, early lesion
  • 2B32.1 – Reactive plasmacytic hyperplasia
  • 2B32.2 – Post-transplant lymphoproliferative disorder, Infectious mononucleosis-like
  • 2B32.3 – Polymorphic post-transplant lymphoproliferative disorder
  • 2B32.Z – Immunodeficiency-associated lymphoproliferative disorders, unspecified

Foundation entity

Immunodeficiency-associated lymphoproliferative disorders – http://id.who.int/icd/entity/1678636940

Allowed postcoordination axes

Part of: 2B32: Immunodeficiency-associated lymphoproliferative disorders › 02: Neoplasms